Showing 1991-2000 of 4166 results for "".
- SightGlass Vision: New 18-Month Data Reinforce DOT Lens Effectivenesshttps://modernod.com/news/sightglass-vision-new-18-month-data-reinforce-dot-lens-effectiveness/2484152/New 18-month clinical data presented by SightGlass Vision at the American Academy of Optometry 2025 annual meeting show that more than half of children wearing DOT spectacle lenses experienced no clinically meaningful myopia progression—nearly 4 times th
- Johnson & Johnson Vision Presents Myopia Research Findings at ARVOhttps://modernod.com/news/johnson-johnson-vision-presents-myopia-research-findings-reports-contact-lens-iol-and-equipment-data-at-arvo-annual-meeting/2479519/Johnson & Johnson Vision will present the first clinical research findings from its comprehensive myopia clinical research program with the Singapore Eye Research Institute (SERI) and Singapore National Eye Centre (SNEC), as well as new data on contact lens and surgical innovations, at the 20
- Johnson & Johnson Vision Expands “Sight For Kids” Program and Unveils “Vision for Good” Community Impact Reporthttps://modernod.com/news/johnson-johnson-vision-expands-sight-for-kids-program-and-unveils-vision-for-good-community-impact-report/2479256/Johnson & Johnson Vision announced the expansion of nonprofit program
- Candida Auris Tied to Vision Loss in Case Reporthttps://modernod.com/news/candida-auris-tied-to-vision-loss-in-case-report/2476883/Infection with Candida auris likely led to panophthalmitis and vision loss in an immune compromised patient, according to a case report published online today in the Annals of Internal Medicine, as
- Johnson & Johnson Vision Highlights New Data on Personalized Vision Approach with Tecnis Family of IOLs and Highlights Progress of Innovative Pipeline at ASCRShttps://modernod.com/news/johnson-johnson-vision-highlights-new-data-on-personalized-vision-approach-with-tecnis-family-of-iols-and-highlights-progress-of-innovative-pipeline-at-ascrs/2476548/Johnson & Johnson Vision announced that a series of new data will be presented that further support advancements and innovations in the treatment of cataracts, dry eye, and laser vision correction. These analyses will be presented at the 2019 American Society of Cataract and Refractive Surger
- EyePoint Pharmaceuticals’ Yutiq for Posterior Segment Uveitis to be Presented at the 2018 ARVO Annual Meetinghttps://modernod.com/news/eyepoint-pharmaceuticals-yutiq-for-posterior-segment-uveitis-to-be-presented-at-the-2018-arvo-annual-meeting/2480232/EyePoint Pharmaceuticals announced that two abstracts supporting the company’s Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for noninfectious posterior segment uveitis have been accepted for presentation at the Association for Research in Vision and Ophtha
- Centricity Vision to Present at ASCRS and Eyeceleratorhttps://modernod.com/news/centricity-vision-to-present-at-ascrs-and-eyecelerator/2482203/Centricity Vision announced that it will present on its recently launched ZEPTOLink IOL Positioning System during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held April 5-8, 2024 in Boston. Additionally, Leonard Borrmann, the company’s newl
- Vision Integrated Partners Completes Refinancinghttps://modernod.com/news/vision-integrated-partners-completes-refinancing/2482123/Vision Integrated Partners (VIP) has successfully completed a recapitalization that consist of $25 million revolving credit facility, a $155 million term loan, and a $12.5 million delayed draw term loan. Proceeds from the credit facilities will be used to refinance existing indebte
- Pixium Vision Receives Takeover Offerhttps://modernod.com/news/pixium-vision-receives-takeover-offer/2481976/Pixium Vision, whose safeguard proceedings were converted into receivership by the Paris Commercial Court on November 13, 2023, announced that the court-appointed administrators have received a takeover offer for the assets and activities of Pixium. The name of the a
- Raindrop Near Vision Inlay Recalledhttps://modernod.com/news/fda-issues-recall-of-raindrop-near-vision-inlay/2476350/A Class I recall of the Raindrop near vision inlay has been issued due to an increased risk of corneal haze, according to the FDA. The owner of the Raindrop inlay, RVO 2.0, doing business as Optics Medical, issued the recall after an October warning letter from the FDA cited a post-approva